Yellow Book Home | Travelers' Health | CDC

Updated September 2, 2024

The original link broke.

You can still access the same Yellow Book resource here:

https://wwwnc.cdc.gov/travel/page/yellowbook-home

---  the original post follows below  ---

2014 Yellow Book Home | Travelers' Health | CDC:

"Explore Travel Health with the new 2014 Yellow Book!

CDC Health Information for International Travel (commonly called the Yellow Book) is published every two years by CDC as a reference for those who advise international travelers about health risks. The Yellow Book is written primarily for health professionals, although others will find it useful."

Follow this link to the CDC Yellow Book (online)

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog

The Exemptee Institute
The Designated Representative Institute

The Health, Drug, Prescription, and GMP Supersite Gift Store 

2011 Predictions - Global Supply Chain

Checkout Bob Ferrari's Blog on Global Supply Chain Business Process and Technology for his series, Supply Chain Matters Top Ten Predictions for Global Supply Chains in 2011.

His well-considered thoughts appear in 3 installments:
Supply Chain Matters Top Ten Predictions for Global Supply Chains in 2011- Part One
Supply Chain Matters Top Ten Predictions for Global Supply Chains in 2011- Part Two
Supply Chain Matters Top Ten Predictions for Global Supply Chains in 2011- Part Three

Return Home: http://drughealth.blogspot.com/

IFPMA Launches 10 Principles On Counterfeit Medicines

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) hopes the The IFPMA Ten Principles on Counterfeit Medicines will highlight the full scope of the problem and demonstrate that the fight against counterfeit medicines is simply about protecting patients’ health.

In a nutshell, here are the 10 principles:

1. Medicine counterfeiting is first and foremost a crime against patients
2. Counterfeit medicines threaten the full spectrum of legitimate medicines.
3. Patents have nothing to do with counterfeiting and counterfeiting has nothing to do with patents.
4. All substandards are not counterfeits.
5. A medicine that is authorized for marketing by one regulatory authority but not by another should not be regarded as counterfeit.
6. Government regulatory and enforcement authorities must be fully vested with the proper power and adequately resourced to fight counterfeits.
7. Stopping the international trade in counterfeit medicines is vital.
8. All stakeholders across the pharmaceutical supply chain must be made aware of the health threats posed by counterfeit medicines and collaborate.
9. Global cooperation is needed
10. The leadership of the World Health Organization (WHO) is crucial.

More Information:
IFPMA launches Ten Principles on Counterfeit Medicines - News Release

Return Home: http://drughealth.blogspot.com/

FDA Final Guidance On ICH Q10 - Quality Control System

• FDA cGMP QSR GMP Online Training Courses - by SkillsPlus International Inc.

Image via Wikipedia

If you follow quality issues in the GMP regulated industry space, you'll want to get up to speed on ICH Q10. Here's what the FDA has to say about this new guidance, FDA - Q10 Pharmaceutical Quality System:

This internationally harmonized guidance is intended to assist pharmaceutical manufacturers by describing a model for an effective quality management system for the pharmaceutical industry, referred to as the pharmaceutical quality system. Throughout this guidance, the term pharmaceutical quality system refers to the ICH Q10 model. ICH Q10 describes one comprehensive model for an effective pharmaceutical quality system that is based on International Organization for Standardization (ISO) quality concepts, includes applicable good manufacturing practice (GMP) regulations, and complements ICH "Q8 Pharmaceutical Development" and ICH "Q9 Quality Risk Management." ICH Q10 is a model for a pharmaceutical quality system that can be implemented throughout the different stages of a product lifecycle. Much of the content of ICH Q10 applicable to manufacturing sites is currently specified by regional GMP requirements. ICH Q10 is not intended to create any new expectations beyond current regulatory requirements. Consequently, the content of ICH Q10 that is additional to current regional GMP requirements is optional.

In summary, the International Conference on Harmonization's (ICH) Q10 attempts to provide a comprehensive model for an effective quality management system by building upon good manufacturing practices (GMP). 

Return Home: http://drughealth.blogspot.com/ 

Prescription Drug Reimportation and Safety - Both Presidential Candidates Support It

• California Board of Pharmacy Designated Representative Training. Board-approved online training programs for drug wholesalers and 3PLs. Provided by SkillsPlus International Inc.

Election time is near, sometimes the candidates have the same view, and sometimes they differ. They happen to agree and reaffirmed their support for allowing Americans to import cheaper prescription drugs from abroad, but both campaigns note that concerns over international drug safety will take precedence in determining this policy, commonly known as drug reimportation. Read this Henry Kaiser Foundation post for more details, "Election 2008 - Both Major Presidential Candidates Support Prescription Drug Reimportation, Cite Need To Ensure Safety." In a nutshell, here are the high points . . .

1. Recent incidents like the tainted heparin from China, highlight the need to ensure drug safety abroad.
2. There's a need to focus on global areas with strong track records of safety.
3. We need to make sure that all imported drugs meet state and federal standards for safety.

Return Home: http://drughealth.blogspot.com/ 

More Than 90 Free Podcasts - International AIDS Conference 2008

What a treasure trove of free podcasts! If you couldn't make it to Mexico City for the 17th International AIDS Conference, held August 3-8, 2008, then check out this massive collection. Keep reading to see the complete listing of podcasts below . . . Here's some information about the folks making this podcast collection available. The mission of the Kaiser Family Foundation is to provide timely, reliable, and non-partisan information on national health issues to policymakers, the media, and the general public. To advance that mission, the Foundation established kaisernetwork.org in November 2000. KaiserNetwork.org makes the following podcasts, in English, available to you. 

TIP: some of the podcasts start with an introduction in Spanish, then are delivered in English. 

Pedro Cahn, M.D., Ph.D., IAS Conference Co-Chair Late Breaker Track C Rapporteur Summary Session Craig McClure, IAS Executive Director Press Conference: The Role of the AIDS Epidemic in Black America in the Global AIDS Epidemic Reaching Millions - Youth, AIDS and the Digital Age Closing Session Official Press Conference Linda Richter, Ph.D., Executive Director, Child Youth Family & Social Development (South Africa) Friday, August 1 Allyson Leacock, Executive Director, Caribbean Broadcast Media Partnership on HIV/AIDS Luis Soto-Ramirez, M.D., IAS Conference Co-Chair Elisabet Fadul, AIDS 2008 Youth Programme Co-Chair Ceci Connolly, Correspondent, Washington Post Food Security, Nutrition and HIV Regional Session: Middle East and North Africa Late Breaker Track B Session 2 The Future of Microbicides: From Vaginal ART to PREP Plenary Session, Day 4 Understanding the Numbers: from HIV Surveillance to HIV National and Global HIV Burden Estimates MenEngage: Developing a Global Movement to Work with Boys and Men for Gender Equality Plenary: Panel Discussion on the State of the Epidemic Official Press Conference Is Religion a Barrier to HIV Prevention? REAL TIME: New Models of Private Sector Engagement Food Security, Livelihoods and HIV: Challenges and Responses HIV and Human Resources: Competing Priorities or Interconnected Solutions? Opening Press Conference Kevin Fenton, M.D., Ph.D., Director, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention CDC's Kevin Fenton Discusses HIV Incidence in the United States HIV Transmission under ART Scaling up Comprehensive Prevention of Mother-to-child Transmission Programmes: Challenges and Lessons Learned from Adapting Global Recommendations to Country Situation Opening Session Universal Access of TB Services to PLHIV: Harnessing Collaboration and Coordination Zonibel Woods, Programme Manager, Ford Foundation Gregg Gonsalves, AIDS and Rights Alliance for Southern Africa Tachi Yamada, M.D., President, Global Health Program, Bill & Melinda Gates Foundation Regional Session: Sub-Saharan Africa HIV/AIDS and Health System Reform: Achieving Universal Coverage Learning by Doing: Scaling up HIV Operations Research in Resource-Limited Settings Monday, August 4 Reclaiming our Lives: Developing Accountability for Positive (PLHIV) Leadership and our Advocacy Priorities Newer Antiretroviral Agents Women's Rights Equal Women's Lives: Violence Against Women and HIV The Lancet Series on HIV Prevention Travel Restrictions on People Living with HIV: Going Against the Grain of Human Rights and Public Health Prevention Working Group Press Conference Official Press Conference Regional Session: Asia-Pacific Where Are We In Achieving UNGASS Targets? Former President Festus Gontebanye Mogae, Botswana Tuesday, August 5 Phill Wilson, CEO, Black AIDS Institute Mark Dybul, U.S. Global AIDS Coordinator, U.S. Department of State Indigenous People, First Nations and Afrodescendants Confronting HIV/AIDS: Breaking the Silence Regional Session: Latin America Financing for Sustainable National Health Care Looking to the Future--The Epidemic in 2031 and New Directions in AIDS Research Moving from Promises to Actions: Building Global and National Commitment for Evidence-Based Approaches to Addressing Stigma and Discrimination Forgotten Truths, Hidden Realities: Addressing the Dynamics of HIV and MSM in Unfavorable Environments Human Security and HIV Achieving Universal Access for Young People Universal ARV Scale Up: Delivering the Second Wave Beyond Barriers: Disabilities and AIDS Beyond the Orphan Crisis: Findings of the Joint Learning Initiative on Children and HIV/AIDS The New Frontiers of Harm Reduction Late Breaker Track B Session 1 AIDS Ambassadors Strengthening Health Systems Through the AIDS Response Regional Session: Eastern Europe and Central Asia Plenary Session, Day 2 Country-Level Advocacy Initiatives that Support Children and AIDS New Frontiers in HIV Prevention Sciences Best Practices for HIV/AIDS Implementers: Highlights from Kampala IAS 20th Anniversary From Commitment to Action: Implementing Effective Responses on Gender and AIDS New Insights Into HIV Transmission and Pathogenesis Positive Synergies Between Health Systems and Global Health Initiatives Vaccines and Microbicides: Where Do We go from Here? Global Financial Architecture Scaling-up HIV Testing and Counseling: A Human Rights and Public Health Imperative Wednesday, August 6 Globalization, Development and Free Trade Agreements (FTAs) The USA HIV Epidemic in 2008 AIDS Vaccines - 2010 and Beyond: Charting a Course for the Future of AIDS Vaccine Research Official Press Conference Universal Access/Universal Crises/Universal Prices Regional Session: Caribbean - Creative Caribbean Approaches to the HIV Epidemic Human Rights, HIV and Sex Work Policy Male Circumcision: To Cut or Not to Cut Kevin De Cock, M.D., Director of HIV/AIDS Department, World Health Organization Plenary Session, Day 3 Official Press Conference Mobile Populations and Globalization Thursday, August 7 Plenary, Day 5 

Additional reading about HIV/AIDS: The First Year: HIV: An Essential Guide for the Newly Diagnosed (First Year, The) 

Previous posts: The Health, Drug, Prescription, and GMP Supersite: Free Health Resources on KP.org (Kaiser Permanente) 

Return Home: http://drughealth.blogspot.com/